Literature DB >> 34986011

Utilizing Two Borrelia bavariensis Isolates Naturally Lacking the PFam54 Gene Array To Elucidate the Roles of PFam54-Encoded Proteins.

Robert E Rollins1, Janna Wülbern1,2, Florian Röttgerding3, Tristan A Nowak4,5, Sabrina Hepner6, Volker Fingerle6, Gabriele Margos6, Yi-Pin Lin4,5, Peter Kraiczy3, Noémie S Becker1.   

Abstract

Lyme borreliosis is the most common vector-borne disease in the Northern Hemisphere, caused by spirochetes belonging to the Borrelia burgdorferi sensu lato species complex, which are transmitted by ixodid ticks. B. burgdorferi sensu lato species produce a family of proteins on the linear plasmid 54 (PFam54), some of which confer the functions of cell adhesion and inactivation of complement, the first line of host defense. However, the impact of PFam54 in promoting B. burgdorferi sensu lato pathogenesis remains unclear because of the hurdles to simultaneously knock out all PFam54 proteins in a spirochete. Here, we describe two Borrelia bavariensis strains, PBN and PNi, isolated from patients naturally lacking PFam54 but maintaining the rest of the genome with greater than 95% identity to the reference B. bavariensis strain, PBi. We found that PBN and PNi less efficiently survive in human serum than PBi. Such defects were restored by introducing two B. bavariensis PFam54 recombinant proteins, BGA66 and BGA71, confirming the role of these proteins in providing complement evasion of B. bavariensis. Further, we found that all three strains remain detectable in various murine tissues 21 days post-subcutaneous infection, supporting the nonessential role of B. bavariensis PFam54 in promoting spirochete persistence. This study identified and utilized isolates deficient in PFam54 to associate the defects with the absence of these proteins, building the foundation to further study the role of each PFam54 protein in contributing to B. burgdorferi sensu lato pathogenesis. IMPORTANCE To establish infections, Lyme borreliae utilize various means to overcome the host's immune system. Proteins encoded by the PFam54 gene array play a role in spirochete survival in vitro and in vivo. Moreover, this gene array has been described in all currently available Lyme borreliae genomes. By investigating the first two Borrelia bavariensis isolates naturally lacking the entire PFam54 gene array, we showed that both patient isolates display an increased susceptibility to human serum, which can be rescued in the presence of two PFam54 recombinant proteins. However, both isolates remain infectious to mice after intradermal inoculation, suggesting the nonessential role of PFam54 during the long-term, but may differ slightly in the colonization of specific tissues. Furthermore, these isolates show high genomic similarity to type strain PBi (>95%) and could be used in future studies investigating the role of each PFam54 protein in Lyme borreliosis pathogenesis.

Entities:  

Keywords:  Borrelia bavariensis; Lyme disease; PFam54 gene array; complement evasion; host-pathogen interaction; innate immunity; spirochetes

Mesh:

Year:  2022        PMID: 34986011      PMCID: PMC8904061          DOI: 10.1128/AEM.01555-21

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   5.005


  95 in total

1.  MRBAYES: Bayesian inference of phylogenetic trees.

Authors:  J P Huelsenbeck; F Ronquist
Journal:  Bioinformatics       Date:  2001-08       Impact factor: 6.937

Review 2.  Complement Evasion Contributes to Lyme Borreliae-Host Associations.

Authors:  Yi-Pin Lin; Maria A Diuk-Wasser; Brian Stevenson; Peter Kraiczy
Journal:  Trends Parasitol       Date:  2020-05-23

3.  Complement evasion by Borrelia burgdorferi: serum-resistant strains promote C3b inactivation.

Authors:  A Alitalo; T Meri; L Rämö; T S Jokiranta; T Heikkilä; I J Seppälä; J Oksi; M Viljanen; S Meri
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

4.  Changes in infectivity and plasmid profile of the Lyme disease spirochete, Borrelia burgdorferi, as a result of in vitro cultivation.

Authors:  T G Schwan; W Burgdorfer; C F Garon
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

5.  A soft tick Ornithodoros moubata salivary protein OmCI is a potent inhibitor to prevent avian complement activation.

Authors:  Amber M Frye; Thomas M Hart; Danielle M Tufts; Sanjay Ram; Maria A Diuk-Wasser; Peter Kraiczy; Anna M Blom; Yi-Pin Lin
Journal:  Ticks Tick Borne Dis       Date:  2019-12-06       Impact factor: 3.744

6.  Multipartite Genome of Lyme Disease Borrelia: Structure, Variation and Prophages.

Authors:  Ira Schwartz; Gabriele Margos; Sherwood R Casjens; Wei-Gang Qiu; Christian H Eggers
Journal:  Curr Issues Mol Biol       Date:  2020-12-17       Impact factor: 2.081

7.  High conservation combined with high plasticity: genomics and evolution of Borrelia bavariensis.

Authors:  Noémie S Becker; Robert E Rollins; Kateryna Nosenko; Alexander Paulus; Samantha Martin; Stefan Krebs; Ai Takano; Kozue Sato; Sergey Y Kovalev; Hiroki Kawabata; Volker Fingerle; Gabriele Margos
Journal:  BMC Genomics       Date:  2020-10-08       Impact factor: 3.969

8.  Complement factor H binding by different Lyme disease and relapsing fever Borrelia in animals and human.

Authors:  Mangesh R Bhide; Raquel Escudero; Emilio Camafeita; Horacio Gil; Isabel Jado; Pedro Anda
Journal:  BMC Res Notes       Date:  2009-07-15

9.  Multilocus sequence typing of Borrelia burgdorferi suggests existence of lineages with differential pathogenic properties in humans.

Authors:  Klara Hanincova; Priyanka Mukherjee; Nicholas H Ogden; Gabriele Margos; Gary P Wormser; Kurt D Reed; Jennifer K Meece; Mary F Vandermause; Ira Schwartz
Journal:  PLoS One       Date:  2013-09-17       Impact factor: 3.240

10.  Infection Kinetics and Tropism of Borrelia burgdorferi sensu lato in Mouse After Natural (via Ticks) or Artificial (Needle) Infection Depends on the Bacterial Strain.

Authors:  Natacha Sertour; Violaine Cotté; Martine Garnier; Laurence Malandrin; Elisabeth Ferquel; Valérie Choumet
Journal:  Front Microbiol       Date:  2018-07-31       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.